newsfilter
← Latest News
GlobeNewswire·

Mesoblast Financial Results and Corporate Update Webcast

NEW YORK, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited ((ASX:MSB, NASDAQ:MESO), global leader in allogeneic cellular medicines for inflammatory diseases, will host a webcast to discuss operational highlights and